Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Treasury Shares: 2020-2025

Historic Treasury Shares for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to $979,608.

  • Mereo BioPharma Group's Treasury Shares fell 7.87% to $1.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year decrease of 7.87%. This contributed to the annual value of $1.2 million for FY2023, which is 7.87% down from last year.
  • According to the latest figures from Q3 2025, Mereo BioPharma Group's Treasury Shares is $979,608, which was down 0.00% from $979,608 recorded in Q2 2025.
  • Mereo BioPharma Group's 5-year Treasury Shares high stood at $1.3 million for Q1 2024, and its period low was $855,375 during Q2 2024.
  • Moreover, its 3-year median value for Treasury Shares was $951,504 (2023), whereas its average is $970,812.
  • Data for Mereo BioPharma Group's Treasury Shares shows a maximum YoY declined of 13.13% (in 2022) over the last 5 years.
  • Quarterly analysis of 4 years shows Mereo BioPharma Group's Treasury Shares stood at $1.7 million in 2020, then fell by 10.82% to $1.5 million in 2021, then decreased by 13.13% to $1.3 million in 2022, then dropped by 7.87% to $1.2 million in 2023.
  • Its Treasury Shares stands at $979,608 for Q3 2025, versus $979,608 for Q2 2025 and $979,608 for Q1 2025.